Co-Delivery of Eugenol and Dacarbazine by Hyaluronic Acid-Coated Liposomes for Targeted Inhibition of Survivin in Treatment of Resistant Metastatic Melanoma

While melanoma remains a challenge for oncologists, possibilities are being continuously explored to fight resistant metastatic melanoma more effectively. Eugenol is reported to inhibit survivin protein in breast cancer cells. Survivin is also overexpressed by melanoma cells, and is known to impart...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Harshita, Mishra, Pawan Kumar, Iqbal, Zeenat, Jaggi, Manu, Madaan, Alka, Bhuyan, Kimi, Gupta, Namita, Gupta, Neha, Vats, Karnika, Verma, Ritu, Talegaonkar, Sushama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523131/
https://www.ncbi.nlm.nih.gov/pubmed/30987266
http://dx.doi.org/10.3390/pharmaceutics11040163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523131/
https://www.ncbi.nlm.nih.gov/pubmed/30987266
http://dx.doi.org/10.3390/pharmaceutics11040163

Ejemplares similares